Patent Assignment
Reel/Frame 076084/0283
Patent Security Agreement
Recorded: 2026-07-30
Pages: 14
Assignor
AUTOLUS LIMITED
Executed: 2026-07-30
Assignee
PERCEPTIVE CREDIT HOLDINGS V, LP, AS ADMINISTRATIVE AGENT
C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK, NEW YORK, 10003
Covered Properties
(103)
Transcription System
Application:
16/470,965 →
Publication:
US US20200095590A1
Compositions and Methods Comprising Engineered Chimeric Antigen Receptor and Modulator of Car
Application:
17/436,673 →
Publication:
US US20220145325A1
CAR T-Cell to Activate the Cellular-Mediated Immune Response through Recognition of Peptide/MHC Complexes
Application:
17/601,684 →
Publication:
US US20220211830A1
Chimeric Cytokine Receptor Comprising a Truncated Cytokine Receptor Domain
Application:
17/628,509 →
Publication:
US US20220289820A1
Trbc Beta Antibody Conjugate
Application:
17/913,649 →
Publication:
US US20230109275A1
Cell
Application:
17/915,637 →
Publication:
US US20230113183A1
Method for Selecting Cells Expressing a Nucleic Acid of Interest
Application:
17/915,689 →
Publication:
US US20230133554A1
Method of Treating Solid Cancer
Application:
17/924,345 →
Publication:
US US20230256093A1
Chimeric Antigen Receptor (CAR) Comprising A CD19-Binding Domain
Cell
Application:
18/158,310 →
Publication:
US US20240033289A1
Retroviral And Lentiviral Vectors
Application:
18/160,032 →
Publication:
US US20240093232A1
Generation of T-Cells by Direct Reprogramming from Fibroblasts and Msc
Application:
18/279,568 →
Publication:
US US20240166996A1
Vectors
Application:
18/504,554 →
Publication:
US US20240309400A1
Chimeric Antigen Receptor
Application:
18/515,458 →
Publication:
US US20240301088A1
Cell Expressing a Car and a Transcription Factor and Its Use
Application:
18/525,271 →
Publication:
US US20240307440A1
Anti-CD307E Single-Domain Antibodies, Uses Thereof in Car T-Cell and for the Treatment of Diseases
Application:
18/570,278 →
Publication:
US US20250289891A1
Nucleic Acid Construct
Application:
18/590,698 →
Publication:
US US20240384278A1
Chimeric Antigen Receptor
Application:
18/597,357 →
Publication:
US US20250019434A1
Chimeric Cytokine Receptor
Application:
18/704,231 →
Publication:
US US20260159570A1
T-Cell Receptor Constant Region 1 Antibody or T-Cell Receptor Constant Region 2 Antibody
Application:
18/794,918 →
Publication:
US US20250333505A1
CD19/C22 Car T-Cell Treatment of High Risk or Relapsed Pediatric Acute Lymphoblastic Leukemia
Application:
18/862,269 →
Publication:
US US20260097122A1
Method
Application:
18/868,402 →
Publication:
US US20250345427A1
Cell
Application:
18/954,189 →
Publication:
US US20250197464A1
Bcma/CD19 Car for Treating Multiple Myeloma
Application:
18/967,332 →
Publication:
US US20250268941A1
Chimeric Antigen Receptor
Application:
18/978,527 →
Publication:
US US20250277047A1
Retroviral and Lentiviral Vectors
Application:
18/987,004 →
Publication:
US US20250388929A1
Car T-Cells Comprising an Anti CD33, an Anti CLL1 and at Least One Further Car Anti CD123 and/or FTL3
Application:
19/021,501 →
Publication:
US US20250381224A1
Chimeric Cytokine Receptor
Application:
19/033,252 →
Publication:
US US20250333538A1
Methods
Application:
19/050,681 →
Publication:
US US20250314655A1
Compositions and Methods Comprising Engineered Chimeric Antigen Receptor and Modulator of Car
Application:
19/073,904 →
Publication:
US US20250296976A1
Chimeric Antigen Receptor
Application:
19/139,245 →
Chimeric Cytokine Receptor, Which Comprises a Truncated IL2RBETA and IL2RGAMMA
Application:
19/166,559 →
Publication:
US US20260263519A1
Chimeric Antigen Receptor
Application:
19/172,331 →
Publication:
US US20260062458A1
Signalling System
Application:
19/178,505 →
Publication:
US US20260085106A1
Cell
Application:
19/281,399 →
Publication:
US US20250353893A1
Anti TRBC1 Antigen Binding Domains
Application:
19/412,451 →
Publication:
US US20260274948A1
Transcription System
Application:
19/412,507 →
Publication:
US US20260193660A1
Cell
Application:
19/459,793 →
Publication:
US US20260224627A1
CD19CAR T-Cell Treatment of Relapsed/Refractory B-Cell Acute Lymphoblastic Leukaemia
Application:
19/487,852 →
Treatment of TRBC1-Positive T Cell Malignancies
Application:
19/491,316 →
Publication:
US US20260263599A1
Method
Application:
19/498,920 →
Chimeric Antigen Receptors Directed Against TRBC1 and TRBC2
Application:
19/500,132 →
Anti-TCRB1 and Anti-TCRB2 T Cells
Application:
19/501,916 →
Methods and Cell Compositions
Application:
19/508,279 →
Products and Methods for Treating Autoimmune Diseases
Application:
19/528,476 →
Method for Producing Engineered Immune Cells
Application:
19/528,489 →
Chimeric Antigen Receptor (Car) Comprising a CD19-Binding Domain
Application:
19/691,108 →
Publication:
US US20260274946A1
Chimeric Antigen Receptor
Chimeric Antigen Receptor
Signalling System
Chimeric Protein
A T Cell Which Co-Expresses a CD19 Chimeric Antigen Receptor and a CD22 Chimeric Antigen Receptor
Retroviral and Lentiviral Vectors
Chimeric Antigen Receptor (CAR) Comprising a CD19-Binding Domain
Nucleic Acid Construct
Chimeric T cell
Chimeric Cytokine Receptors and Encoding Nucleic Acids
Chimeric Receptor with Ligand Binding Exodomain and Cytokine and T Cell Signalling Endodomains
Signalling System
Chimeric Protein
Chimeric Cytokine Receptors and Encoding Nucleic Acids
Chimeric Antigen Receptor
Method of Preparing T Cells with Increased Activity
Methods of depleting malignant T-cells.
Chimeric Antigen Receptor
Retroviral And Lentiviral Vectors
Chimeric Antigen Receptor (Car) Comprising a CD19-Binding Domain
Chimeric Protein
Anti TRBC1 Antigen Binding Domains
Cell
Cell
Car T-Cells Comprising Transcriptional Circuits
Polypeptide
Plasmid System
Cell Comprising a Chimeric Antigen Receptor or a Transgenic T-Cell Receptor and Comprising a Chimeric TNF Receptor
Methods for Treating Cancer or Modulating T Cells or Nk Cells in a Subject by Administering Cells Comprising Chimeric Transmembrane Proteins
Methods for Treating Cancer or Modulating T Cells or Nk Cells in a Subject with Cancer by Administering Cells Comprising Chimeric Cytokine Receptors
Chimeric Antigen Receptor
A CD79-Specific Chimeric Antigen Receptor
Retroviral and Lentiviral Vectors
Chimeric Antigen Receptor
Nucleic Acid Construct
Molecular Assessment of Trbc Usage
Chimeric Antigen Receptor
T-Cell Receptor Constant Region 1 Antibody or T-Cell Receptor Constant Region 2 Antibody
Binding Domain
Anti TRBC1 Antigen Binding Domains
Cell
Chimeric Receptor Comprising a Ligand Binding Domain and an Endodomain Comprising a Cytokine Receptor Endodomain and an Intracellular T Cell Signalling Domain
Virus-Like Particle
Chimeric Antigen Receptor
Cytolytic Immune Cell Comprising Bcma- and CD19-Specific Chimeric Antigen Receptors
Compositions and Methods Comprising Engineered Chimeric Antigen Receptor and Modulator of Car
Antigen-Binding Domain
Chimeric Transmembrane Protein Comprising Antibody Dimerization Domains and a Type I Cytokine Receptor Endodomain, Encoding Nucleic Acids Thereof and Methods of Use Thereof
Anti TRBC1 Antigen Binding Domains
Engineered Cytolytic Immunecell
Methods
Method for Depleting Malignant T-Cells
Methods
Method for Depleting Malignant T-Cells
A Cell Lexpressing Two Chimeric Antigen Receptors (Cars) at the Cell Surface
Cell
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 20, 2019
From: PULÉ, MARTIN; THOMAS, SIMON; CORDOBA, SHAUN
To: AUTOLUS LIMITED
Reel/Frame 049535/0858 →
Assignment of Assignor's Interest
Dec 17, 2021
From: PULÉ, MARTIN; PEDDAREDDIGARI, VIJAY; ITIN, CHRISTIAN
To: AUTOLUS LIMITED
Reel/Frame 058416/0201 →
Assignment of Assignor's Interest
Jan 4, 2022
From: PULÉ, MARTIN; CORDOBA, SHAUN; THOMAS, SIMON; ONUOHA, SHIMOBI
To: AUTOLUS LIMITED
Reel/Frame 058538/0796 →
Assignment of Assignor's Interest
Mar 9, 2022
From: PULÉ, MARTIN; CORDOBA, SHAUN; ONUOHA, SHIMOBI; THOMAS, SIMON
To: AUTOLUS LIMITED
Reel/Frame 059213/0100 →
Assignment of Assignor's Interest
Oct 5, 2022
From: MCKENZIE, CALLUM; CORDOBA, SHAUN; PULÉ, MARTIN
To: AUTOLUS LIMITED
Reel/Frame 061319/0856 →
Assignment of Assignor's Interest
Oct 5, 2022
From: ONUOHA, SHIMOBI; FERRARI, MATHIEU; AKBAR, ZULAIKHA; BUGHDA, REYISA
To: AUTOLUS LIMITED
Reel/Frame 061320/0220 →
Assignment of Assignor's Interest
Oct 5, 2022
From: MCKENZIE, CALLUM; CORDOBA, SHAUN; PULÉ, MARTIN
To: AUTOLUS LIMITED
Reel/Frame 061319/0988 →
Assignment of Assignor's Interest
Nov 10, 2022
From: PERUTA, MARCO DELLA; RIGHI, MATTEO; AGLIARDI, GIULIA; PULÉ, MARTIN
To: AUTOLUS LIMITED
Reel/Frame 061715/0001 →
Change of Name
May 5, 2023
From: UCL BUSINESS PLC
To: UCL BUSINESS LTD
Reel/Frame 063557/0692 →
Assignment of Assignor's Interest
May 5, 2023
From: UCL BUSINESS LTD
To: AUTOLUS LIMITED
Reel/Frame 063551/0098 →
Assignment of Assignor's Interest
May 5, 2023
From: PULÉ, MARTIN; KONG, KHAI; CORDOBA, SHAUN
To: UCL BUSINES PLC
Reel/Frame 063550/0909 →
Assignment of Assignor's Interest
May 5, 2023
From: PEDDAREDDIGARI, VIJAY; BESWICK, RICHARD; SHORT, JOHN; PULÉ, MARTIN
To: AUTOLUS LIMITED
Reel/Frame 063551/0421 →
Assignment of Assignor's Interest
Jun 9, 2023
From: PULE, MARTIN; MEKKAOUI, LEILA; AMROLIA, PERSIS; GHORASHIAN, SARA
To: UCL BUSINESS PLC
Reel/Frame 063912/0169 →
Assignment of Assignor's Interest
Jun 9, 2023
From: UCL BUSINESS LTD
To: AUTOLUS LIMITED
Reel/Frame 063912/0341 →
Change of Name
Jun 9, 2023
From: UCL BUSINESS PLC
To: UCL BUSINESS LTD
Reel/Frame 063956/0229 →
Assignment of Assignor's Interest
Dec 14, 2023
From: PULÉ, MARTIN; SILLIBOURNE, JAMES; CORDOBA, SHAUN
To: AUTOLUS LIMITED
Reel/Frame 065868/0325 →
Assignment of Assignor's Interest
Jan 8, 2024
From: KINNA, ALEXANDER; FERRARI, MATHIEU; ONUOHA, SHIMOBI; PULE, MARTIN
To: AUTOLUS LIMITED
Reel/Frame 066046/0641 →
Assignment of Assignor's Interest
Jan 8, 2024
From: PULÉ, MARTIN; ANDERSON, JOHN; THOMAS, SIMON
To: UCL BUSINESS PLC
Reel/Frame 066047/0020 →
Assignment of Assignor's Interest
Jan 8, 2024
From: UCL BUSINESS LTD
To: AUTOLUS LIMITED
Reel/Frame 066047/0137 →
Assignment of Assignor's Interest
Jan 8, 2024
From: PULÉ, MARTIN; BAI, YUCHEN
To: AUTOLUS LIMITED
Reel/Frame 066047/0377 →
Assignment of Assignor's Interest
Jan 8, 2024
From: UCL BUSINESS PLC
To: UCL BUSINESS LTD
Reel/Frame 066221/0328 →
Assignment of Assignor's Interest
Jan 8, 2024
From: PULÉ, MARTIN; THOMAS, SIMON; CORDOBA, SHAUN; LIM, WEN CHEAN
To: AUTOLUS LIMITED
Reel/Frame 066047/0323 →
Assignment of Assignor's Interest
Feb 5, 2024
From: UCL BUSINESS LTD
To: AUTOLUS LIMITED
Reel/Frame 066385/0634 →
Assignment of Assignor's Interest
Feb 5, 2024
From: PULE, MARTIN; ANDERSON, JOHN; THOMAS, SIMON
To: UCL BUSINESS PLC
Reel/Frame 066520/0975 →
Change of Name
Feb 5, 2024
From: UCL BUSINESS PLC
To: UCL BUSINESS LTD
Reel/Frame 066494/0087 →